NutriDex

The Supplement Research Compendium
🌾

Maltodextrin

processed starch

Ubiquitous starch-derived filler with a high glycemic punch and an unsettled gut-barrier signal

Mixed evidence 🍬Sweeteners & Additives

✚ Updated · How we grade evidence

Evidence tier
Mixed
Research weight
Citations
13 verified / 13
Classification
Sweeteners & Additives
❝
What the evidence says. Conflicting results across studies; benefit uncertain.

What is Maltodextrin?

Maltodextrin (processed starch) is a sweetener or food additive used for bulking agent and texture/body builder in low-fat, powdered, and reduced-sugar products. NutriDex grades the human evidence as Mixed. Maltodextrin is a non-sweet, easily digestible carbohydrate made by partial hydrolysis of corn, potato, rice, or wheat starch into short glucose chains (dextrose equivalent under 20). It is one of the most common processed-food ingredients in the world, used as a bulking agent, thickener, carrier, and sports-energy carbohydrate, and is GRAS in the US (21 CFR 184.1444) with no numerical ADI assigned by FDA, EFSA, or JECFA because it is metabolized like ordinary starch. For the general population the weight of human evidence is reassuring at dietary levels, but it is metabolically a rapidly absorbed glucose source (glycemic index roughly 85-105, higher than table sugar), and a body of mechanistic and animal work has raised a still-unresolved signal about effects on the intestinal mucus barrier and bacterial adhesion relevant to inflammatory bowel disease.

Purported Benefits

✓Bulking agent and texture/body builder in low-fat, powdered, and reduced-sugar products
✓Carrier and spray-drying aid for flavors, colors, sweeteners, and supplements
✓Fast-absorbing, low-osmolality energy carbohydrate for endurance/sports drinks and gels
✓Improves solubility, mouthfeel, and freeze-thaw stability
✓Provides ~4 kcal/g; effectively a digestible glucose polymer (NOT a zero-calorie or non-glycemic ingredient)

Dosing & Compounds

Typical Dose
FDA: Generally Recognized as Safe (GRAS) under 21 CFR 184.1444, with no maximum level and no numerical ADI. EFSA and JECFA: no numerical ADI required (acceptable daily intake 'not specified'), as it is digested and absorbed as glucose like other starches. Wheat-derived maltodextrin must be declared as a gluten source in the EU; refined products are generally below the 20 ppm gluten threshold.
Active Compounds
No E-number in the EU; not classed as an additive there but as a food/starch hydrolysate ingredient (CAS 9050-36-6)Brand/source examples: Maltrin, Star-Dri, Glucidex, Fantomalt; derived from corn (most common in US), wheat, potato, tapioca, or riceFound in: soft drinks and sports drinks, infant formula, instant puddings/soups/sauces, salad dressings, candy, baked goods, sugar substitutes (as a carrier for sucralose/stevia/aspartame blends), protein powders, and many 'sugar-free' products

Safety & Cautions

At normal dietary levels maltodextrin is not a recognized toxicity or cancer hazard, and no regulator has restricted it. The honest caveats are metabolic and gastrointestinal. Metabolically it behaves as rapidly digestible glucose with a glycemic index higher than sucrose, so it raises blood glucose and is not 'sugar-free' in any physiological sense — a concern for people with diabetes or insulin resistance despite 'no added sugar' labeling. The most studied signal is gut-related: Nickerson 2012 showed maltodextrin enhances adhesion of Crohn's-associated adherent-invasive E. coli to intestinal epithelium via type-1 pili, and Laudisi 2019 showed dietary maltodextrin induces endoplasmic-reticulum stress in goblet cells, depletes the protective Muc2 mucus layer, and worsens chemically induced colitis in mice. These are predominantly mechanistic/animal/in-vitro findings; robust human outcome data are lacking, and gastroenterology consensus is that this warrants caution and further study for people with IBD rather than avoidance by the general public. Large doses can cause osmotic GI symptoms (bloating, gas, loose stools), and wheat-derived product is relevant to celiac/gluten-sensitive individuals. Educational only — always check with your doctor or pharmacist before combining Maltodextrin with any medicine.

Key Studies ★ 13 studies

Meta-analysis Rudiansyah 2025 ✓ Full text
Systematic review and meta-analysis of RCTs in type 2 diabetes found resistant dextrin supplementation significantly lowered HbA1c (WMD approximately -0.30%) versus control, with effects on fasting glucose and insulin (moderate-quality evidence).
systematic review Almeida 2020, Compr Rev Food Sci Food Saf ✓ Full text
Systematic review of human and animal studies found the majority reporting maltodextrin effects on gut microbiota and barrier function, but concluded human evidence remains insufficient to establish clinical harm at dietary intakes.
Systematic review Eur J Nutr (systematic review) 2022 ✓ Source
Systematic review of placebo-controlled trials (70 RCTs analyzed from 216 studies) found 60% reported maltodextrin-induced physiological effects, challenging its validity as an inert placebo and indicating direct effects on human gut physiology.
regulatory review EFSA Panel (NDA/ANS) carbohydrate review ✓ Source
Maltodextrin is digested and absorbed as glucose in the small intestine, contributing ~4 kcal/g and behaving glycemically like other rapidly available carbohydrates rather than as fiber.
RCT Lansink 2024 ✓ Full text
Double-blind crossover RCTs in healthy individuals, people with obesity, and people with type 2 diabetes showed the slowly digestible carbohydrate oligomalt produced lower postprandial glucose iAUC and 38-60% lower insulin response than maltodextrin across all populations.
RCT Baljon 2022 ✓ Full text
Double-blind, randomized, crossover trial in healthy adults found resistant maltodextrin increased fecal bifidobacteria counts and stool wet weight, indicating prebiotic-type modulation of beneficial gut bacteria.
RCT Tanaka 2022 ✓ Full text
24-week randomized, double-blind, placebo-controlled trial in 29 Japanese subjects with HbA1c >6% found resistant maltodextrin reduced virulent gut metabolites and increased fecal Fusicatenibacter saccharivorans approximately two-fold.
regulatory FDA 21 CFR 184.1444 ✓ Source
Affirms maltodextrin (DE <20, from corn/potato/rice starch) as GRAS with no quantitative use limit, used per good manufacturing practice.
Review Brand-Miller 2026 ✓ PubMed
A central role for dietary sugars in human evolution
animal Zangara 2022, Front Immunol ✓ Source
Maltodextrin impaired the intestinal mucus barrier and accelerated colitis in mice through direct actions on the epithelium, independent of broad microbiota shifts.
mechanistic / animal Nickerson 2015, Gut Microbes ✓ Source
Maltodextrin suppressed cellular antibacterial responses and impaired mucosal clearance of Salmonella, deregulating intestinal anti-microbial defense in cell and mouse models.
animal Laudisi 2019, Cell Mol Gastroenterol Hepatol ✓ Source
Dietary maltodextrin (5%) induced goblet-cell ER stress, Muc2 mucus depletion, and exacerbated DSS colitis in mice; the ER-stress inhibitor TUDCA reversed the effect.
in vitro / mechanistic Nickerson 2012, PLOS ONE ✓ Full text
Maltodextrin enhanced Crohn's-associated adherent-invasive E. coli adhesion to intestinal epithelial cells via type-1 pili and increased biofilm formation, independent of CEACAM6.
13 sources cited · 13 verified Search all studies on PubMed ↗

Common questions about Maltodextrin

What is Maltodextrin used for?

Maltodextrin is most often taken for Bulking agent and texture/body builder in low-fat, powdered, and reduced-sugar products, Carrier and spray-drying aid for flavors, colors, sweeteners, and supplements, Fast-absorbing, low-osmolality energy carbohydrate for endurance/sports drinks and gels, Improves solubility, mouthfeel, and freeze-thaw stability. Ubiquitous starch-derived filler with a high glycemic punch and an unsettled gut-barrier signal

Does Maltodextrin work — what does the evidence say?

Mixed evidence. Conflicting results across studies; benefit uncertain. Maltodextrin is a non-sweet, easily digestible carbohydrate made by partial hydrolysis of corn, potato, rice, or wheat starch into short glucose chains (dextrose equivalent under 20). It is one of the most common processed-food ingredients in the world, used as a bulking agent, thickener, carrier, and sports-energy carbohydrate, and is GRAS in the US (21 CFR 184.1444) with no numerical ADI assigned by FDA, EFSA, or JECFA because it is metabolized like ordinary starch. For the general population the weight of human evidence is reassuring at dietary levels, but it is metabolically a rapidly absorbed glucose source (glycemic index roughly 85-105, higher than table sugar), and a body of mechanistic and animal work has raised a still-unresolved signal about effects on the intestinal mucus barrier and bacterial adhesion relevant to inflammatory bowel disease.

What is the typical dose of Maltodextrin?

FDA: Generally Recognized as Safe (GRAS) under 21 CFR 184.1444, with no maximum level and no numerical ADI. EFSA and JECFA: no numerical ADI required (acceptable daily intake 'not specified'), as it is digested and absorbed as glucose like other starches. Wheat-derived maltodextrin must be declared as a gluten source in the EU; refined products are generally below the 20 ppm gluten threshold.

Is Maltodextrin safe? Any cautions or side effects?

At normal dietary levels maltodextrin is not a recognized toxicity or cancer hazard, and no regulator has restricted it. The honest caveats are metabolic and gastrointestinal. Metabolically it behaves as rapidly digestible glucose with a glycemic index higher than sucrose, so it raises blood glucose and is not 'sugar-free' in any physiological sense — a concern for people with diabetes or insulin resistance despite 'no added sugar' labeling. The most studied signal is gut-related: Nickerson 2012 showed maltodextrin enhances adhesion of Crohn's-associated adherent-invasive E. coli to intestinal epithelium via type-1 pili, and Laudisi 2019 showed dietary maltodextrin induces endoplasmic-reticulum stress in goblet cells, depletes the protective Muc2 mucus layer, and worsens chemically induced colitis in mice. These are predominantly mechanistic/animal/in-vitro findings; robust human outcome data are lacking, and gastroenterology consensus is that this warrants caution and further study for people with IBD rather than avoidance by the general public. Large doses can cause osmotic GI symptoms (bloating, gas, loose stools), and wheat-derived product is relevant to celiac/gluten-sensitive individuals.

How many studies support Maltodextrin?

NutriDex cites 13 sources for Maltodextrin, graded "Mixed".

Cite this page
APA

Peh, D. (2026). Maltodextrin (processed starch): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 16 Sept 2026, from https://nutridex.info/s/maltodextrin

BibTeX
@misc{nutridex_maltodextrin,
  author       = {Peh, Daryl},
  title        = {Maltodextrin (processed starch): Benefits, Dosage, Side Effects \& Evidence},
  year         = {2026},
  howpublished = {NutriDex --- The Supplement Research Compendium},
  url          = {https://nutridex.info/s/maltodextrin},
  note         = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-09-16}
}

For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.

← Back to the full dex · All substances